2494 results

• Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026

  November 13, 2025

  Irvin Jackson

  A series of case management conferences have been scheduled for hair relaxer litigation throughout 2026, leading up to expected bellwether trials in 2027.

• Update on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing

  November 5, 2025

  Irvin Jackson

  A federal judge will hold a hearing on Thursday with hair relaxer lawsuit parties in order to update the court on the status of the ongoing litigation.

• Talc Powder Cancer Verdicts and Lawsuits Continue To Pile Up Against Johnson & Johnson

  October 30, 2025

  Irvin Jackson

  A Florida jury has ordered Johnson & Johnson to pay $20 million to the family of a man who died of mesothelioma after using the company's talc-based products for 50 years.

• Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations

  October 29, 2025

  Irvin Jackson

  Sanofi indicates Dupixent sales are growing stronger as the medication gathers more indications for use worldwide, despite recent cancer concerns.

• Hair Relaxer Injury Lawsuit Against L’Oreal, Strength of Nature Cleared To Move Forward

  October 20, 2025

  Irvin Jackson

  The Georgia Supreme Court has ruled that a woman’s lawsuit over injuries allegedly caused by chemical hair relaxers can proceed, rejecting claims that the deadline for filing her case began nearly 30 years ago, when she first bought the product in 1995.

• Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit

  October 17, 2025

  Irvin Jackson

  Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward.

• J&J Faces Talcum Powder Lawsuit in UK Brought By More Than 3,000 Plaintiffs

  October 17, 2025

  Irvin Jackson

  More than 3,000 people in the U.K. have signed onto a joint talcum powder lawsuit against Johnson & Johnson and its Kenvue spin-off over claims the products were contaminated with asbestos.

• Carvykti Black Box Warning About Gastrointestinal Risks Added By FDA

  October 13, 2025

  Irvin Jackson

  The FDA is warning that the CAR-T therapy Carvykti is linked to an increased risk of a gastrointestinal inflammation that has led to deaths due to gut perforation and sepsis.

• Lawyers in Talcum Powder Bellwether Lawsuit To Meet for Final Pretrial Conference Nov. 5

  October 10, 2025

  Irvin Jackson

  Both plaintiffs and defendants have named their lead trial counsel for the first federal bellwether trial over talcum powder cancer claims.

• Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link

  October 8, 2025

  Russell Maas

  Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.